ZEVRA THERAPEUTICS, INC. (ZVRA) › Shareholders' EquityZEVRA THERAPEUTICS, INC. (ZVRA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$19.18M2013: -$24.27M2014: -$48.51M2015: -$10.12M2016: -$18.70M2017: -$57.52M2018: -$66.57M2019: -$74.46M2020: -$66.41M2021: $101.66M2022: $75.12M2023: $61.86M2024: $39.67M2025: $154.66M$154.66M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$154.66M+289.9%2024$39.67M-35.9%2023$61.86M-17.6%2022$75.12M-26.1%2021$101.66M+253.1%2020-$66.41M+10.8%2019-$74.46M-11.9%2018-$66.57M-15.7%2017-$57.52M-207.6%2016-$18.70M-84.7%2015-$10.12M+79.1%2014-$48.51M-99.9%2013-$24.27M-26.6%2012-$19.18M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share